pyrroles has been researched along with Cancer of Mediastinum in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A | 1 |
| Fellowes, A; Hanna, DM; Hansford, JR; Mechinaud, F; Vedururu, R | 1 |
| Bailey, AM; Meric-Bernstam, F; Mills, GB; Pagliaro, LC; Rao, P; Shaw, KR; Subbiah, V; Ward, JF | 1 |
| Ahn, H; Ahn, JH; Choi, JS; Kim, TW; Kim, YR; Koh, JM; Lee, DH; Lee, JL; Lee, JS; Park, I; Park, KS; Park, TS | 1 |
| Bosl, GJ; Carousso, M; Feldman, DR; Ginsberg, MS; Ishill, N; Motzer, RJ; Patil, S; Turkula, S | 1 |
| Andrejak, M; Basille, D; Bentayeb, H; Boutemy, M; Dayen, C; Douadi, Y; Fournier, C; Garidi, R; Kanaan, M; Lecuyer, E | 1 |
| Ganser, A; Grünwald, V; Janssen, S; Karstens, JH; Morgan, M; Seidel, C; Welte, T | 1 |
| Bajorin, DF; Bosl, GJ; Carousso, M; Feldman, DR; Ginsberg, MS; Motzer, RJ; Patil, S; Sheinfeld, J; Trinos, MJ | 1 |
| Bazan, F; Bouchet, S; Curtit, E; Kalbacher, E; Maurina, T; Montange, D; Nguyen, T; Pivot, X; Royer, B; Thiery-Vuillemin, A | 1 |
2 trial(s) available for pyrroles and Cancer of Mediastinum
| Article | Year |
|---|---|
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Disease-Free Survival; Drug Resistance, Neoplasm; High-Throughput Nucleotide Sequencing; Humans; Indoles; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Platinum Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Pyrroles; Retroperitoneal Neoplasms; Sunitinib; Testicular Neoplasms; Young Adult | 2014 |
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Indoles; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Pyrroles; Secondary Prevention; Sunitinib; Testicular Neoplasms | 2010 |
7 other study(ies) available for pyrroles and Cancer of Mediastinum
| Article | Year |
|---|---|
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid | 2013 |
A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 3; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Molecular Targeted Therapy; Mutation; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2014 |
Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Humans; Indoles; Liver Neoplasms; Male; Mediastinal Neoplasms; Pheochromocytoma; Pyrroles; Sunitinib | 2009 |
Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
Topics: Adult; Antineoplastic Agents; Bronchial Fistula; Bronchial Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Pyrroles; Sunitinib | 2010 |
Recall pneumonitis during systemic treatment with sunitinib.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Mediastinal Neoplasms; Middle Aged; Neoplasms, Radiation-Induced; Pneumonia; Prognosis; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2010 |
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Indoles; Kaplan-Meier Estimate; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Pyrroles; Retroperitoneal Neoplasms; Retrospective Studies; Sunitinib; Suramin; Testicular Neoplasms; Topotecan; Treatment Outcome; Young Adult | 2012 |
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Drug Monitoring; Humans; Indoles; Kidney Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Pancreatic Neoplasms; Pyrroles; Renal Dialysis; Sunitinib | 2011 |